Breaking News Instant updates and real-time market news.

GOOG

Alphabet

$1,098.25

6.96 (0.64%)

, GOOGL

Alphabet Class A

$1,106.92

7.52 (0.68%)

11:23
01/21/19
01/21
11:23
01/21/19
11:23

France's National Data Protection Commission fines Google 50M euros

France's National Data Protection Commission imposed a financial penalty of 50M euros against Alphabet's Google, in accordance with the General Data Protection Regulation, for "lack of transparency, inadequate information and lack of valid consent regarding the ads personalization." The agency explained in a statement, "On 25 and 28 May 2018, the National Data Protection Commission received group complaints from the associations None Of Your Business and La Quadrature du Net. LQDN was mandated by 10 000 people to refer the matter to the CNIL. In the two complaints, the associations reproach GOOGLE for not having a valid legal basis to process the personal data of the users of its services, particularly for ads personalization purposes." On the basis of the inspections carried out, the CNIL's restricted committee responsible for examining breaches of the Data Protection Act observed two types of breaches of the GDPR. The agency added, "This is the first time that the CNIL applies the new sanction limits provided by the GDPR. The amount decided, and the publicity of the fine, are justified by the severity of the infringements observed regarding the essential principles of the GDPR: transparency, information and consent." Reference Link

GOOG

Alphabet

$1,098.25

6.96 (0.64%)

GOOGL

Alphabet Class A

$1,106.92

7.52 (0.68%)

  • 24

    Jan

  • 24

    Jan

  • 04

    Feb

  • 04

    Feb

  • 25

    Feb

  • 03

    Mar

GOOG Alphabet
$1,098.25

6.96 (0.64%)

01/14/19
SBSH
01/14/19
NO CHANGE
Target $44
SBSH
Neutral
Roku valuation still 'relatively high' despite 48% selloff, says Citi
Citi analyst Mark May lowered his price target for Roku to $44 from $60 while keeping a Neutral rating on the shares. The stock closed Friday down 59c to $39.57. The analyst lists five main reasons for maintaining a Neutral rating despite the stock's 48% selloff since the peak on October 1, 2018. The analyst sees signs that Google (GOOG, GOOGL) and Amazon (AMZN) are becoming more competitive in the smart TV market, which he believes could result in pressure on Roku's account growth and/or expenses. Further, despite the recent selloff, Roku's valuation is still relatively high, May tells investors in a research note. The analyst also sees potential for Roku to accelerate its international expansion investments, which he notes could weigh on near-term earnings. In addition, May believes Q4 revenue and gross profit forecasts are already aggressive for Roku. Lastly, the consensus sell-side 2019 adjusted EBITDA forecast of $29M is above management's stated target of "managing the business toward breakeven," May tells investors in a research note.
01/10/19
01/10/19
UPGRADE
Target $39

Buy
BofA/Merrill upgrades Twitter two notches to Buy following social user survey
As previously reported, BofA Merrill Lynch analyst Justin Post upgraded Twitter (TWTR) two notches, to Buy from Underperform, after conducting a survey in early December of more than 1,000 U.S. consumers ages 18-65. The survey showed Twitter penetration increased to 48% of respondents and the percentage of users reporting deceased usage fell slightly. Improving metrics in the 18-29 demographic suggest more younger users are turning to Twitter, noted Post. The analyst, who sees Twitter as a strong play on video ad dollars shifting online and advertisers potentially diversifying their ad spending, raised his price target on Twitter shares to $39. Post added in the note to investors that the survey suggested Google (GOOGL) and Facebook's (FB) Instagram have the most positive usage trends, while the negative effects from Snap's (SNAP) redesign appear to have continued.
01/10/19
KEYB
01/10/19
NO CHANGE
KEYB
KeyBanc remains bullish on MongoDB as Amazon unveils DocumentDB
KeyBanc analyst Brent Bracelin Amazon (AMZN) has unveiled a new cloud database called DocumentDB that emulates API functionality similar to MongoDB (MDB). The analyst believes this increases the competitive overlap with Amazon, but also validates the need for MongoDB's patented document-oriented database. We remain bullish on the prospects for MongoDB to sustain high growth based on a large $63B TAM that can support multiple players, differentiated functionality in MongoDB version 4.0 versus Amazon DocumentDB emulating version 3.6, and proprietary data analysis that validates robust MongoDB growth on Microsoft's (MSFT) Azure and Google (GOOGL; GOOG) Cloud suggests customers increasingly desire multi-cloud functionality.
01/10/19
MSCO
01/10/19
DOWNGRADE
Target $29
MSCO
Underweight
Morgan Stanley sees revenue headwinds for Yelp, downgrades to Underweight
As previously reported, Morgan Stanley analyst Brian Nowak downgraded Yelp (YELP) to Underweight from Equal Weight as he identified three building revenue headwinds that he believes will lead to negative revisions and underperformance of the stock. First, Nowak sees the increased flexibility of Yelp's new non-term agreements leading to lower spend per customer. Second, he sees pricing compression risk given that his ad pricing analysis shows Yelp's average cost per click is still over four times higher than Google (GOOGL) and Facebook (FB). Third, he expects Yelp's declining user base to further hold back spend per customer. Nowak cut his price target on Yelp shares to $29 from $31, noting that his revised FY19 and FY20 EBITDA estimates are now 2% and 6%, respectively, below consensus.
GOOGL Alphabet Class A
$1,106.92

7.52 (0.68%)

TODAY'S FREE FLY STORIES

VRTX

Vertex

$183.73

7.49 (4.25%)

07:23
10/22/19
10/22
07:23
10/22/19
07:23
Recommendations
Vertex analyst commentary  »

Vertex price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 19

    Mar

ORTX

Orchard Therapeutics

$12.09

0.1 (0.83%)

07:22
10/22/19
10/22
07:22
10/22/19
07:22
Hot Stocks
Orchard Therapeutics 'on track' to submit MAA for MLD in 1H20 »

Orchard remains on track…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

BABA

Alibaba

$173.57

4.39 (2.59%)

07:22
10/22/19
10/22
07:22
10/22/19
07:22
Recommendations
Alibaba analyst commentary  »

Daiwa expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 19

    Nov

ORTX

Orchard Therapeutics

$12.09

0.1 (0.83%)

07:21
10/22/19
10/22
07:21
10/22/19
07:21
Hot Stocks
Orchard Therapeutics presents data from OTL-200 in patients with MLD »

Orchard Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

SWI

SolarWinds

$19.05

0.22 (1.17%)

07:20
10/22/19
10/22
07:20
10/22/19
07:20
Downgrade
SolarWinds rating change  »

SolarWinds downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

CHTR

Charter

$438.01

-2.45 (-0.56%)

07:20
10/22/19
10/22
07:20
10/22/19
07:20
Recommendations
Charter analyst commentary  »

Charter price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

NVCN

Neovasc

$3.72

0.17 (4.79%)

07:18
10/22/19
10/22
07:18
10/22/19
07:18
Hot Stocks
Neovasc announces multiple presentations featuring Neovasc Reducer »

Neovasc announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KDMN

Kadmon

$3.08

0.17 (5.84%)

07:17
10/22/19
10/22
07:17
10/22/19
07:17
Hot Stocks
Kadmon reports FDA approval of Clovique generic product »

Kadmon Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTU

Intuit

$262.05

-0.49 (-0.19%)

07:17
10/22/19
10/22
07:17
10/22/19
07:17
Downgrade
Intuit rating change  »

Intuit downgraded to In…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

QTRH

Quarterhill

$1.29

0.05 (4.03%)

07:16
10/22/19
10/22
07:16
10/22/19
07:16
Hot Stocks
Quarterhill names David Cortens as interim CFO, succeeding Shaun McEwan »

Quarterhill announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONCY

Oncolytics

$0.47

-0.0138 (-2.83%)

, PFE

Pfizer

$36.45

-0.01 (-0.03%)

07:16
10/22/19
10/22
07:16
10/22/19
07:16
Hot Stocks
Oncolytics, PrECOG announce collaboration for Bracelet-1 study in metastatic BC »

Oncolytics Biotech (ONCY)…

ONCY

Oncolytics

$0.47

-0.0138 (-2.83%)

PFE

Pfizer

$36.45

-0.01 (-0.03%)

MKGAY

Merck KGaA

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 29

    Oct

  • 06

    Nov

  • 06

    Nov

  • 07

    Dec

KMT

Kennametal

$29.76

-0.97 (-3.16%)

07:16
10/22/19
10/22
07:16
10/22/19
07:16
Recommendations
Kennametal analyst commentary  »

Kennametal price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 05

    Nov

  • 14

    Nov

ETON

Eton Pharmaceuticals

$5.66

-0.395 (-6.52%)

07:14
10/22/19
10/22
07:14
10/22/19
07:14
Hot Stocks
Eton Pharmaceuticals announces FDA approval of Biorphen injection »

Eton Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Mar

WDAY

Workday

$154.10

-0.54 (-0.35%)

07:14
10/22/19
10/22
07:14
10/22/19
07:14
Upgrade
Workday rating change  »

Workday upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UPS

UPS

$118.56

1.23 (1.05%)

07:13
10/22/19
10/22
07:13
10/22/19
07:13
Hot Stocks
UPS announces retirement of COO Jim Barber »

UPS announced COO Jim…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 29

    Oct

IPG

Interpublic Group

$20.79

0.14 (0.68%)

07:11
10/22/19
10/22
07:11
10/22/19
07:11
Earnings
Interpublic Group 'on track' to deliver high end of 2%-3% organic growth in 2019 »

Consensus $8.65B. CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

AAPL

Apple

$240.49

4.2 (1.78%)

07:11
10/22/19
10/22
07:11
10/22/19
07:11
Recommendations
Apple analyst commentary  »

KeyBanc views near-term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

PG

Procter & Gamble

$119.04

1.55 (1.32%)

07:10
10/22/19
10/22
07:10
10/22/19
07:10
Hot Stocks
Procter & Gamble: Q1 operating profit margin increased 280 basis points »

Operating profit margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

PG

Procter & Gamble

$119.04

1.55 (1.32%)

07:09
10/22/19
10/22
07:09
10/22/19
07:09
Hot Stocks
Procter & Gamble: Q1 reported gross margin increased 180 basis points »

Q1 Reported gross margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

VCYT

Veracyte

$26.18

1.52 (6.16%)

07:09
10/22/19
10/22
07:09
10/22/19
07:09
Hot Stocks
Veracyte announces preliminary nasal swab test clinical data »

Veracyte announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 12

    Dec

PRVB

Provention Bio

$6.09

-0.48 (-7.31%)

07:09
10/22/19
10/22
07:09
10/22/19
07:09
Hot Stocks
Provention Bio announces results from Phase 2a PRINCE clinical trial »

Provention Bio announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLAN

Anaplan

$44.35

0.34 (0.77%)

07:09
10/22/19
10/22
07:09
10/22/19
07:09
Upgrade
Anaplan rating change  »

Anaplan upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IPG

Interpublic Group

$20.79

0.14 (0.68%)

07:08
10/22/19
10/22
07:08
10/22/19
07:08
Earnings
Interpublic Group reports Q3 adjusted EPS 49c, consensus 47c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

CSIQ

Canadian Solar

$18.51

0.39 (2.15%)

07:07
10/22/19
10/22
07:07
10/22/19
07:07
Hot Stocks
Canadian Solar awarded 30 MWp project in Japan »

Canadian Solar announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

BBY

Best Buy

$71.51

0.89 (1.26%)

07:06
10/22/19
10/22
07:06
10/22/19
07:06
Hot Stocks
Best Buy announces free next-day shipping for holiday season »

Best Buy announced free…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.